Meet our Head of Cell and Gene Therapy, Abayomi Johnson, at ESGCT Congress 2026 in Hamburg, between 27-30 October 2026.

Discover how SynGenSys is advancing promoter engineering for cell therapies through our tissue and cell-type targetted promoter libraries and de novo promoter design capabilities.

Connect with us to explore how tailored promoter solutions could help you achieve your desired gene expression profiles.